Quintiles is a provider of biopharmaceutical development and commercial outsourcing services for drugs on the market.
Business Model:
Revenue: $0
Employees: 10,001-1
Quintiles was acquired by
IMS Health.
The acquisition happend on 2016-05-03.
Details of the transaction were not public
Address:
City: Austin
State: Texas
Zip:
Country: United States
Quintiles helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies. What drives us: the promise of medical breakthroughs that will improve and save lives. They invite you to explore the possibilities of partnering with Quintiles throughout the product lifecycle.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/9/2013
Ticker Symbol:
Q
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
6/2001 | NitroMed | Series E | 0 |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
10/2001 | D Pharm LTD. | Series D | 0 |
4/2006 | Bayhill Therapeutics | Venture Round | 0 |
5/2005 | Bayhill Therapeutics | Series B | 0 |
10/2001 | D Pharm LTD. | Series D | 0 |
6/2001 | NitroMed | Series E | 0 |
Announced Date | Name | Price |
---|---|---|
7/2014 | Encore Health Resources | |
9/2013 | Novella | |
8/2012 | Expression Analysis | |
10/2011 | Advion Inc. | |
10/2011 | VCG &a; Associates | |
10/2011 | Outcome Sciences | |
12/2008 | Targeted Molecular Diagnostics | |
5/2008 | Eidetics | |
10/2007 | Bio-Trials | |
10/2002 | Health Research Solutions |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|